EUVIMEDEUVIMED entdecken
Leitlinie

The Role of Psilocybin in End-of-Life Care: Evidence, Mechanisms, and Guidelines

Mackenzie Unsworth, Mary Lou Galantino, Robert Sandoval

Oncology Rehabilitation in Practice · 2025

DOI: 10.26890/hntj1494 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Oncology Rehabilitation in Practice, 2025. Verfasst von Mackenzie Unsworth und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article aims to provide a brief overview of the evidence and mechanisms for psilocybin use in EOL care. Additionally, this article will provide guidelines for clinicians to assess patient use and integrate psilocybin into their clinical practice with respect to its current legal status.

Zitieren

APA

Unsworth, M., Galantino, M. L., & Sandoval, R. (2025). The Role of Psilocybin in End-of-Life Care: Evidence, Mechanisms, and Guidelines. Oncology Rehabilitation in Practice. https://doi.org/10.26890/hntj1494

Vancouver

Unsworth M, Galantino ML, Sandoval R. The Role of Psilocybin in End-of-Life Care: Evidence, Mechanisms, and Guidelines. Oncology Rehabilitation in Practice. 2025. doi:10.26890/hntj1494

BibTeX
@article{Unsworth2025,
  author = {Unsworth, Mackenzie and Galantino, Mary Lou and Sandoval, Robert},
  title = {The Role of Psilocybin in End-of-Life Care: Evidence, Mechanisms, and Guidelines},
  journal = {Oncology Rehabilitation in Practice},
  year = {2025},
  doi = {10.26890/hntj1494}
}
Kostenlos starten →